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Basic, translational, and clinical research in the area of stem
cell biology is currently aimed at investigating the ability of
adipose stem cells (ASCs) to enhance tissue and organ regen-
eration and suggest that ASCs in 3D scaffolds may have
potential for application in wound healing, orthopaedic tis-
sue repair, and tissue reconstruction after surgery [1, 2].
The development of regenerative medicine strategies requires
an appropriate phenotypically stable and well-characterized
cell source and a 3-dimensional scaffold or “smart” biomate-
rial (novel “intelligent” biomaterial with appropriate physical
properties that can support in vivo the commitment of
ASCs), together with a suitable microenvironment to provide
the necessary cues and signals for cell growth and tissue
formation. Tissue reconstruction represents one of the
most significant challenges in all surgical procedures. This
special issue includes a collection of papers that have
focused on these aspects in regenerative medicine and tis-
sue engineering.
G. Storti and colleagues [3] focused their review on recent
discoveries that have involved the use of ASCs in bone tissue
engineering and analysed the interaction of ASCs with scaf-
folds that can support osteogenic commitment. Moreover,
S.-J. Oh and colleagues [4] explored the therapeutic efficacy
of ASCs and their secretome in auricular cartilage regenera-
tion and highlighted that the expression of collagen type II,
TGF, beta1, and IGF-1 was significantly higher after ASC
injection in an auricular defect. M. Milewska and colleagues
[5] demonstrated that copper sulphate supplementation of
ASCs can have a beneficial effect on tendon regeneration
but not inducing tenogenic differentiation and improve the
recruitment of MSC to the site of injury and prevent the
effects of inflammation oxidative stress. M. Neubauer and
colleagues [6] demonstrated that blood products such as
platelet-rich plasma (PRP), hyperacute serum, and standard
fetal calf serum have a significant influence on the viability
and differentiation potential of ASCs especially in an osteo-
genic and chondrogenic context. In addition, M. Conese
and colleagues [7] showed that ASCs represented an alterna-
tive strategy to increase the healing rate of hard-to-heal
wounds with the use of dermal matrix, collagen scaffolds,
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and platelet-rich plasma. Moreover, X. Qin and colleagues
[8] demonstrated that ASCs rapidly promote fistula healing,
and C. Hu and colleagues [9] showed that ASCs have a strong
protective effect on degenerative diseases of the retina.
Tissue engineering represents a collection of technolo-
gies combining biomaterials and stem cells, provides tools
for regenerative medicine, and is expanding tremendously
from biomaterial science towards a genuine multidisciplin-
ary area, integrating biology, medicine, and various engi-
neering sciences. S. Zhou [10] prepared an acellular
matrix using ASC sheets. This novel biomaterial possesses
good recellularization capacity and excellent biocompati-
bility. Moreover, O.A. Mohiuddin and coworkers [11]
showed that decellularized adipose tissue-derived hydrogel
is a cytocompatible scaffold, which supports the adipo-
genic and osteogenic differentiation of ASCs, and J.J. dos
Santos Machado et al. [12] performed an animal study
using a solution containing 1% hyaluronic acid and ASC
injected subcutaneously. The solution tested in this study
did not result in systemic, biochemical, or anatomic alter-
ations that could represent toxicity symptoms. Commonly
utilized in vitro models employ human or mouse preadi-
pocyte cell lines in a 2-dimensional (2D) format. However,
3D tissue engineering scaffolds are better able to mimic
the in vivo cellular microenvironment and more effectively
recapitulate the physiological setting, resulting in improved
localization, attachment, proliferation, and differentiation
of ASCs. R. Bender et al. [13] conducted a study using
3-dimensional cultures and ObaGel, a thermoresponsive
gel with a structure that is driven by cell-mediated extra-
cellular matrix remodelling, and demonstrated that a com-
bination of primary SVF cells and ObaGel scaffolds can be
used to create a 3D in vitro construct with functional
properties mimicking a humanized adipose depot.
We know from these studies and from many other pub-
lished studies that ASCs have regenerative potential and are
used in a significant number of clinical trials with a good
immunomodulatory effect. Despite these advances, the func-
tional immunomodulatory capacity of these cells is not yet
fully understood. H.Y. Zhang and colleagues [14] founded
that ASCs with miR-129-5p knockdown exhibited enhanced
immunosuppressive capacity, as evidenced by reduced
expression of proinflammatory factors, with concurrent
increased expression of inducible nitric oxide synthases
(iNOS) and nitric oxide (NO) production. ASCs with miR-
129-5p knockdown alleviated inflammatory bowel disease
and promoted tumour growth in vivo. Moreover, J.S. Heo
[15] examined the effect of MSC-induced macrophages on
inflammation and immune modulation and proposed that
MSC-induced macrophages may be used as a novel stem
cell-based cell-free therapy for the treatment of immune-
mediated inflammatory disorders.
The current special issue focused on the potential role
of ASCs in tissue engineering and regenerative medicine,
presenting new information about implantable biocompat-
ible materials, and advancing the knowledge of ASCs and
biomaterials with potential for further development along
with future stem cell-based therapeutics and technology
platforms.
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